These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3178818

  • 1. Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Baba M, Schols D, Pauwels R, Balzarini J, De Clercq E.
    Biochem Biophys Res Commun; 1988 Sep 30; 155(3):1404-11. PubMed ID: 3178818
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.
    Wang X, Miyake H, Okamoto M, Saito M, Fujisawa J, Tanaka Y, Izumo S, Baba M.
    Mol Pharmacol; 2002 Jun 30; 61(6):1359-65. PubMed ID: 12021397
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of human T-lymphotropic virus type I gene expression by the Streptomyces-derived substance EM2487.
    Wang X, Okamoto M, Kawamura M, Izumo S, Baba M.
    Antivir Chem Chemother; 2002 May 30; 13(3):177-83. PubMed ID: 12448690
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro.
    Nakashima H, Okubo K, Honda Y, Tamura T, Matsuda S, Yamamoto N.
    AIDS; 1989 Oct 30; 3(10):655-8. PubMed ID: 2574582
    [Abstract] [Full Text] [Related]

  • 5. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
    Baba M, Pauwels R, Herdewijn P, De Clercq E, Desmyter J, Vandeputte M.
    Biochem Biophys Res Commun; 1987 Jan 15; 142(1):128-34. PubMed ID: 3028398
    [Abstract] [Full Text] [Related]

  • 6. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Nakashima H, Perno CF, Walker RT, Miyasaka T.
    Biochem Biophys Res Commun; 1989 Dec 29; 165(3):1375-81. PubMed ID: 2575380
    [Abstract] [Full Text] [Related]

  • 7. Antiretroviral activity of thiosemicarbazone metal complexes.
    Pelosi G, Bisceglie F, Bignami F, Ronzi P, Schiavone P, Re MC, Casoli C, Pilotti E.
    J Med Chem; 2010 Dec 23; 53(24):8765-9. PubMed ID: 21121632
    [Abstract] [Full Text] [Related]

  • 8. Sulfonic acid polymers are potent inhibitors of HIV-1 induced cytopathogenicity and the reverse transcriptases of both HIV-1 and HIV-2.
    Tan GT, Wickramasinghe A, Verma S, Hughes SH, Pezzuto JM, Baba M, Mohan P.
    Biochim Biophys Acta; 1993 Apr 30; 1181(2):183-8. PubMed ID: 7683207
    [Abstract] [Full Text] [Related]

  • 9. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
    Balzarini J, Mitsuya H, De Clercq E, Broder S.
    Int J Cancer; 1986 Mar 15; 37(3):451-7. PubMed ID: 2419266
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
    Baba M, Pauwels R, Balzarini J, Herdewijn P, De Clercq E.
    Biochem Biophys Res Commun; 1987 Jun 30; 145(3):1080-6. PubMed ID: 3649230
    [Abstract] [Full Text] [Related]

  • 11. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Balzarini J, Pauwels R, Baba M, Robins MJ, Zou RM, Herdewijn P, De Clercq E.
    Biochem Biophys Res Commun; 1987 May 29; 145(1):269-76. PubMed ID: 3496089
    [Abstract] [Full Text] [Related]

  • 12. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 29; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate.
    Fujiwara M, Ijichi K, Tokuhisa K, Katsuura K, Shigeta S, Konno K, Wang GY, Uemura D, Yokota T, Baba M.
    Antimicrob Agents Chemother; 1996 Jan 29; 40(1):271-3. PubMed ID: 8787923
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).
    Ito M, Sato A, Hirabayashi K, Tanabe F, Shigeta S, Baba M, De Clercq E, Nakashima H, Yamamoto N.
    Antiviral Res; 1988 Dec 11; 10(6):289-98. PubMed ID: 3250333
    [Abstract] [Full Text] [Related]

  • 15. Suramin in the treatment of AIDS: mechanism of action.
    De Clercq E.
    Antiviral Res; 1987 Jan 11; 7(1):1-10. PubMed ID: 2432836
    [Abstract] [Full Text] [Related]

  • 16. Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells.
    Nakashima H, Harada S, Yamamoto N.
    Med Microbiol Immunol; 1987 Jan 11; 176(4):189-98. PubMed ID: 2441239
    [Abstract] [Full Text] [Related]

  • 17. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
    Schols D, Baba M, Pauwels R, Desmyter J, De Clercq E.
    Proc Natl Acad Sci U S A; 1989 May 11; 86(9):3322-6. PubMed ID: 2566170
    [Abstract] [Full Text] [Related]

  • 18. Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro.
    Baba M, Schols D, Nakashima H, Pauwels R, Parmentier G, Meijer DK, De Clercq E.
    J Acquir Immune Defic Syndr (1988); 1989 May 11; 2(3):264-71. PubMed ID: 2470892
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.
    Ito M, Baba M, Sato A, Pauwels R, De Clercq E, Shigeta S.
    Antiviral Res; 1987 Jul 11; 7(6):361-7. PubMed ID: 2445284
    [Abstract] [Full Text] [Related]

  • 20. Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
    Balzarini J, Mitsuya H, De Clercq E, Broder S.
    Biochem Biophys Res Commun; 1986 Apr 14; 136(1):64-71. PubMed ID: 3010977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.